Form 4 for GYRE GYRE THERAPEUTICS, INC.

Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001140361-25-000339 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MTI	2025-01-06	2024-01-03+	GYRE	Ma Songjiang	Pres, Dir	S - Sale	$11.89	-4,000	2.92M	-0.1%	-$47.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-03	S	D	833	$11.85	2,918,467	I By Spouse	—	—	(F4) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.73 to $12.27. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2025-01-03	S	D	1,167	$11.03	2,919,300	I By Spouse	—	—	(F3) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.73 to $11.70. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
3	Common	Common Stock	2025-01-02	S	D	2,000	$12.40	2,920,467	I By Spouse	—	—	(F2) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.99 to $12.80. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.